deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT03418558

Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib. (RESCUE)

Open-label, Phase II Study of Trastuzumab Emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib: HERACLES RESCUE. (HER2 Amplification for Colo-rectaL Cancer Enhanced Stratification - REchallenge With her2 Selective Cytotoxic Uptake of Emtansine)

Sponsor: Fondazione del Piemonte per l'Oncologia

Conditions Metastatic Colorectal Cancer
Interventions Trastuzumab emtansine
Updated 8 times since 2018 Last updated: Oct 29, 2018 Started: Jul 8, 2015 Primary completion: Jun 30, 2019 Completion: Jun 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Metastatic Colorectal Cancer, this trial is ongoing. The trial is conducted by Fondazione del Piemonte per l'Oncologia and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Nov 2020 · 24 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  5. Nov 2020 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Nov 2018 — Nov 2020 [monthly]

    Recruiting PHASE2

  2. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  3. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fondazione del Piemonte per l'Oncologia
Data source: Fondazione del Piemonte per l'Oncologia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations